Conserved Phosphoprotein Networks Identify Actionable Adhesion/Wnt and Metallothionein Modules in Cholangiocarcinoma
Authors:
- Sirinya SitthirakSSSirinya Sitthirak
- Sittiruk RoytrakulSRSittiruk Roytrakul
- Arporn WangwiwatsinAWArporn Wangwiwatsin
- Nisana NamwatNisana Namwat
- Poramate KlanritPKPoramate Klanrit
- Hasaya DokduangHDHasaya Dokduang
- Prakasit Sa-NgiamwiboolPSPrakasit Sa-Ngiamwibool
- Attapol TitapunATAttapol Titapun
- Apiwat JareanratAJApiwat Jareanrat
- Vasin ThanasukarnVTVasin Thanasukarn
- Natcha KhuntikeoNKNatcha Khuntikeo
- Teh Bin TeanTTTeh Bin Tean
Open Access
- 30 January 2026
- journal article
- research article
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 63
Abstract
Background/Objectives: Cholangiocarcinoma (CCA) is a very aggressive biliary carcinoma characterised by significant molecular heterogeneity and restricted treatment alternatives. Despite genomic and proteomic investigations revealing recurrent changes, the signalling dynamics influencing tumour behaviour remain inadequately comprehended. Methods: We conducted high-resolution Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS)-based phosphoproteomics on paired tumour and surrounding tissues from 13 CCA patients in Northeast Thailand, meticulously sampling four geographically unique tumour areas for each patient. Our analysis concentrated on phosphoproteins consistently identified across all regions, delineating strong tumour-specific and cohort-wide phosphorylation signatures. Results: Notwithstanding considerable inter-patient variability, two conserved signalling modules were identified: an adhesion/Wnt axis regulated by hyperphosphorylated CTNNB1 protein (β-catenin) and a metal-handling module facilitated by metallothionein-1G (MT1G) protein and metallothionein-2A (MT2A) protein. Pathway enrichment identified focal adhesion, ECM-receptor interaction, cytoskeletal modulation, and mineral absorption as critical activities. Conclusions: This study elucidates conserved oncogenic pathways by analysing phosphoproteomic signatures across regional and patient-level variability, emphasising phosphoproteomics as a robust framework for biomarker and therapeutic development in CCA.Keywords
Funding Information
- the National Science Research and Innovation Fund
- National Research Council of Thailand
- Walailak University (WU69226)
This publication has 40 references indexed in Scilit:
- β-catenin as a key regulator of the cisplatin response in tumor cellsClinical and Experimental Medicine, 2025
- Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumorsBiochemical and Biophysical Research Communications, 2024
- Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targetsCellular Signalling, 2023
- Proteogenomic characterization of cholangiocarcinomaHepatology, 2022
- Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinomaCancer Cell, 2022
- Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimensiScience, 2021
- Toward understanding the origin and evolution of cellular organismsProtein Science, 2019
- Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate CancerCell, 2016
- Toggling a conformational switch in Wnt/β‐catenin signaling: Regulation of Axin phosphorylationBioEssays, 2013
- Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cellsCancer Letters, 2013